Managing cancer pain poorly responsive to systemic opioid therapy.

Managing cancer pain poorly responsive to systemic opioid therapy.

Item
http://www.wikidata.org/entity/Q39438580
P2X receptors in sensory neurons co-cultured with cancer cells exhibit a decrease in opioid sensitivity.Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain.CB1 and CB2 receptor agonists promote analgesia through synergy in a murine model of tumor painA decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer painIntravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.Genome-wide identification and functional analyses of microRNA signatures associated with cancer pain.Characterization of a rat model of metastatic prostate cancer bone pain.Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis
P2860

Managing cancer pain poorly responsive to systemic opioid therapy.

Item
http://www.wikidata.org/entity/Q39438580
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Managing cancer pain poorly responsive to systemic opioid therapy.
@en
Managing cancer pain poorly responsive to systemic opioid therapy.
@nl
type
label
Managing cancer pain poorly responsive to systemic opioid therapy.
@en
Managing cancer pain poorly responsive to systemic opioid therapy.
@nl
prefLabel
Managing cancer pain poorly responsive to systemic opioid therapy.
@en
Managing cancer pain poorly responsive to systemic opioid therapy.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
Managing cancer pain poorly responsive to systemic opioid therapy
@en
P2093
P304
P31
P433
P478
P577
P698
P921